Time to full approval of novel anticancer medicines granted accelerated approval and implications for reform of the accelerated approval pathway

被引:0
|
作者
Hwang, T. [1 ]
Molto, C. [2 ]
Puy, M. Borrell [3 ]
Tibau, A. [2 ]
机构
[1] Brigham & Womens Hosp, Urol Surg, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA USA
[3] Hosp De La Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain
关键词
D O I
10.1016/j.annonc.2023.09.2660
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1706P
引用
收藏
页码:S931 / S931
页数:1
相关论文
共 50 条
  • [1] TIME TO APPROVAL OF NOVEL CANCER MEDICINES GRANTED ACCELERATED APPROVAL AND IMPLICATIONS FOR REFORM OF THE ACCELERATED APPROVAL PATHWAY
    Hwang, Thomas
    Tibau, Ariadna
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E941 - E941
  • [2] Evidence Required for Drugs Granted Accelerated Approval
    Tanimoto, Tetsuya
    Kosugi, Kazuhiro
    Tsuda, Kenji
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (24): : 2492 - 2493
  • [4] Accelerated approval of medicines: fit for purpose?
    Breckenridge, Alasdair
    Liberti, Lawrence
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (06) : 379 - 380
  • [5] Accelerated approval of medicines: fit for purpose?
    Alasdair Breckenridge
    Lawrence Liberti
    [J]. Nature Reviews Drug Discovery, 2018, 17 : 379 - 380
  • [6] FDA accelerated approval of anticancer agents
    Ning, Y. M.
    Johnson, J. R.
    Farrell, A. T.
    Maher, V. E.
    Justice, R. L.
    Pazdur, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] ACCELERATED APPROVAL
    NIGHTINGALE, SL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (24): : 3262 - 3262
  • [9] Evidence Required for Drugs Granted Accelerated Approval Reply
    Naci, Huseyin
    Kesselheim, Aaron S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (24): : 2493 - 2494
  • [10] Pediatric Drugs, Accelerated Approval, and Prospects for Reform
    Jeromie Ballreich
    Hyung-Seok Kim
    Mariana Socal
    [J]. Pediatric Drugs, 2024, 26 : 5 - 8